Comparison of long‐term outcomes of 50 and 100 mg rt‐PA in the management of acute pulmonary thromboembolism

Background Pulmonary thromboembolism (PTE) is a life‐threatening disease. In this study, we aimed to evaluate long‐term outcomes of the use of 50 mg recombinant tissue‐type plasminogen activator (rt‐PA) in the management of PTE in terms of relapse, pulmonary hypertension (PH), mortality and hemorrha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The clinical respiratory journal 2018-04, Vol.12 (4), p.1628-1634
Hauptverfasser:	Yilmazel Ucar, Elif, Araz, Omer, Kerget, Bugra, Yilmaz, Nafiye, Akgun, Metin, Saglam, Leyla
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Aged Dose-Response Relationship, Drug Female Fibrinolytic Agents - administration & dosage Follow-Up Studies Hospital Mortality - trends Humans long‐term outcomes Male Middle Aged Mortality Pulmonary Embolism - diagnosis Pulmonary Embolism - drug therapy Pulmonary Embolism - mortality pulmonary thromboembolism Recombinant Proteins Retrospective Studies Survival Rate - trends Thromboembolism thrombolytic therapy Thrombolytic Therapy - methods Time Factors Tissue Plasminogen Activator - administration & dosage Treatment Outcome Turkey - epidemiology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!